Source: American journal of cancer research. Unidade: FM
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, CÉLULAS-TRONCO, NEOPLASIAS DE CABEÇA E PESCOÇO
ABNT
SILVA, Luan Cesar et al. Oral squamous cell carcinoma cancer stem cells have different drug sensitive to pharmacological NFκB and histone deacetylation inhibition. American journal of cancer research, v. 13, n. 12, p. 6038-6050, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57914. Acesso em: 02 out. 2024.APA
Silva, L. C., Leite, A. A., Borgato, G. B., Wagner, V. P., Martins, M. D., Loureiro, F. J. A., et al. (2023). Oral squamous cell carcinoma cancer stem cells have different drug sensitive to pharmacological NFκB and histone deacetylation inhibition. American journal of cancer research, 13( 12), 6038-6050. Recuperado de https://observatorio.fm.usp.br/handle/OPI/57914NLM
Silva LC, Leite AA, Borgato GB, Wagner VP, Martins MD, Loureiro FJA, Lopes MA, Santos-Silva AR, Sperandio M, Kowalski LP. Oral squamous cell carcinoma cancer stem cells have different drug sensitive to pharmacological NFκB and histone deacetylation inhibition [Internet]. American journal of cancer research. 2023 ; 13( 12): 6038-6050.[citado 2024 out. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57914Vancouver
Silva LC, Leite AA, Borgato GB, Wagner VP, Martins MD, Loureiro FJA, Lopes MA, Santos-Silva AR, Sperandio M, Kowalski LP. Oral squamous cell carcinoma cancer stem cells have different drug sensitive to pharmacological NFκB and histone deacetylation inhibition [Internet]. American journal of cancer research. 2023 ; 13( 12): 6038-6050.[citado 2024 out. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57914